Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (291-300 of 400) with videos related to

Pageof 40
Sort By:
Hepatology (Baltimore, Md.)|November 2, 2018
Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine AminotransferaseYa-Hui Wang, Ya-Hui Chuang, Chih-Feng Wu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 3, 2020
Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trialsYasuhiro Asahina, Chun-Jen Liu, Edward Gane, et al.
Microbiology Spectrum|November 29, 2023
Healthy diet intervention reverses the progression of NASH through gut microbiota modulationSuraphan Panyod, Wei-Kai Wu, Meng-Yun Hu, et al.
Liver Cancer|March 13, 2024
Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan CriteriaChian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, et al.
Hepatology International|May 29, 2023
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis BShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Medicine|March 11, 2016
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C InfectionWan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, et al.
Gut|June 16, 2012
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patientsQuan Yuan, Liu-Wei Song, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsMing-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2008
Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trialChen-Hua Liu, Chun-Jen Liu, Chih-Lin Lin, et al.
Gut|April 26, 2014
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
Pageof 40

Showing results (291-300 of 400) with videos related to

Sort By:
Pageof 40
Hepatology (Baltimore, Md.)|November 2, 2018
Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine AminotransferaseYa-Hui Wang, Ya-Hui Chuang, Chih-Feng Wu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 3, 2020
Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trialsYasuhiro Asahina, Chun-Jen Liu, Edward Gane, et al.
Microbiology Spectrum|November 29, 2023
Healthy diet intervention reverses the progression of NASH through gut microbiota modulationSuraphan Panyod, Wei-Kai Wu, Meng-Yun Hu, et al.
Liver Cancer|March 13, 2024
Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan CriteriaChian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, et al.
Hepatology International|May 29, 2023
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis BShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
Medicine|March 11, 2016
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C InfectionWan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, et al.
Gut|June 16, 2012
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patientsQuan Yuan, Liu-Wei Song, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsMing-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2008
Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trialChen-Hua Liu, Chun-Jen Liu, Chih-Lin Lin, et al.
Gut|April 26, 2014
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
Pageof 40